Primary endpoint met in the 8-week treatment study (highly statistically significant). Co-administered group had a 4.4% reduction in weight compared to 1.6% for the placebo group (p
Month: March 2025
New Pacific Metals Announces Executive Changes
VANCOUVER, BC, March 31, 2025 /PRNewswire/ – (TSX: NUAG) (NYSE American: NEWP) (“New Pacific” or the “Company”) announces that Andrew Williams will be stepping down as Chief Executive Officer (“CEO”) and Director of the company effective April 15. The Company also announces that it has…
TriPost Partners with Invesco Real Estate Income Trust Inc. to Acquire Minority Equity Stake in Class-A Student Housing Community in Arizona
TriPost’s Asset Solutions Strategy Completes Inaugural Secondary Market Transaction, Leveraging its Deep Track Record of Investing in Real Estate Operators NEW YORK, March 31, 2025 /PRNewswire/ — TriPost Capital Partners, LLC (“TriPost”), a real estate private equity firm focused on…
BTQ Technologies Chief Quantum Officer Dr. Gavin Brennen to Join Fireside Chat on Quantum Funding and Policy at Quantum Industry Day in Sydney
BTQ’s Dr. Gavin Brennen to Speak at Quantum Industry Day in Sydney: BTQ Technologies’ Chief Quantum Officer, Dr. Gavin Brennen, will join a fireside chat titled “Funding and Policy for Quantum Technologies” at Quantum Industry Day in Sydney, Australia, to discuss funding opportunities,…
Star Holdings Announces Successful Debt Extensions and Authorizes $10 Million Share Repurchase Program
Related amendments made to financing arrangements and management agreement NEW YORK, March 31, 2025 /PRNewswire/ — Star Holdings (NASDAQ: STHO) (the “Company”) announced the following: Share Repurchase Program The Company’s Board of Trustees has authorized the repurchase of up to $10…
Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD
Primary endpoint met, with TSND-201 demonstrating statistically significant placebo-adjusted CAPS-5 improvement of -9.64 points on Day 64 (p = 0.011) TSND-201 demonstrated rapid improvements, with a statistically significant placebo-adjusted CAPS-5 improvement of -8.00 points on Day 10 (p…
Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil
Kazia to receive USD $1 million from Vivesto for the intellectual property and trademark assets rights to the oncology drug candidate, Cantrixil SYDNEY, March 31, 2025 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or “the Company”), an oncology-focused drug…
Calamos Announces Cap Ranges of Principal Protected Bitcoin ETFs April Series on the Heels of a Successful Inaugural Launch
METRO CHICAGO, Ill., March 31, 2025 /PRNewswire/ — John Koudounis, President and CEO of Calamos, announced the planned April launch of the three new ETFs in the World’s First Downside Protected Bitcoin ETF Suite, offering Bitcoin upside growth with 100% (CBOA), 90% (CBXA), and 80% (CBTA)…
AMPLIFY Leadership Team to Promote New Services at Mass Torts Made Perfect (MTMP), April 1-3 at the Wynn Hotel in Las Vegas
MIAMI, March 31, 2025 /PRNewswire/ — AMPLIFY, the premier legal marketing agency known for world-class video and digital strategy, is expanding into the mass torts space to help top law firms find the right clients to take on systemic abuses, including defective products and drugs,…
Chad W. Phillips Appointed As Global Head of Nuveen Real Estate
NEW YORK, March 31, 2025 /PRNewswire/ — Nuveen, the investment manager of TIAA, announced today that Chad W. Phillips will serve as Global Head of Nuveen Real Estate, effective immediately, as the firm activates long-standing succession plans following Chris McGibbon’s decision to retire…
